At a glance
- Originator MotoGen; Nonindustrial source
- Developer Nonindustrial source
- Class Analgesics; Anti-inflammatories; Antiglaucomas; Antineoplastics; Antivirals; Cytoprotectives; Eye disorder therapies; Piperidines; Radioprotectives; Skin disorder therapies; Small molecules; Vascular disorder therapies
- Mechanism of Action Free radical scavengers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer; Chemotherapy-induced damage; Radiation injuries; Rheumatoid arthritis; Septic shock; Spinal cord injuries
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Spinal-cord-injuries in USA (Intraperitoneal)
- 28 Jun 2004 Preclinical trials in Spinal cord injuries in USA (Intraperitoneal)
- 26 Jul 2000 Preclinical development for Septic shock in United Kingdom (Unknown route)